Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices 32123 

102 of the Ethics in Government Act, 5 

U.S.C. app. sec. 102, as amended by the 

Stop Trading on Congressional 

Knowledge Act of 2012 (Pub. L. 112– 

105) (STOCK Act) and OGE’s 

implementing financial disclosure 

regulations at 5 CFR part 2634. 

In 2013, OGE sought and received 

approval for the OGE Form 278e, an 

electronic version of the Form 278, 

implemented pursuant to the e-filing 

system mandated under section 11(b) of 

the STOCK Act. The OGE Form 278e 

collects the same information as the 

OGE Form 278. In 2014, OGE sought 

and received approval to incorporate the 

OGE Form 278e into its new Integrity efiling application. Integrity has been in 

use since January 1, 2015, and OGE now 

requires filers to use a version of the 

OGE Form 278e rather than the old OGE 

Form 278. The version of the Form 278e 

that is produced by Integrity is a 

streamlined output report format that 

presents only the filer’s inputs in given 

categories and does not report other 

categories not selected by the filer. 

On October 5, 2016, OGE published a 

proposed rule for amending 5 CFR part 

2634. See 81 FR 69204–69238 (October 

5, 2016). The proposed modifications to 

the OGE Form 278e revise the 

instructions to reflect the changes to the 

financial disclosure regulation, if 

adopted as final. Specifically, OGE 

proposes to: Revise the reporting period 

for termination reports to include the 

entire preceding calendar year if a 

required annual report has not been 

filed; revise the income disclosure 

requirement to include only received 

income; revise the ‘‘widely diversified’’ 

criterion for purposes of determining 

whether a fund qualifies as an 

‘‘excepted investment fund;’’ add a new 

feature (checkbox) for purposes of 

managing early termination report filing 

on the Integrity version of the Form 

278e; clarify the Definition section of 

Part 2; clarify when a source of 

compensation need not be disclosed and 

the method for disclosing the existence 

of such sources; and eliminate the 

disclosure of transactions that occurred 

before the reporting individual became 

subject to the public financial disclosure 

requirements. 

OGE is also proposing to update the 

Privacy Act statement in accordance 

with changes to the applicable system of 

records and to make certain minor 

formatting changes and corrections to 

the instructions and one of the data 

entry fields. 

Request for Comments: Agency and 

public comment is invited specifically 

on the need for and practical utility of 

this information collection, the accuracy 

of OGE’s burden estimate, the 

enhancement of quality, utility and 

clarity of the information collected, and 

the minimization of burden (including 

the use of information technology). 

Comments received in response to this 

notice will be summarized for, and may 

be included with, the OGE request for 

extension of OMB paperwork approval. 

The comments will also become a 

matter of public record. 

Approved: July 3, 2018. 

David Apol, 

Acting Director and General Counsel, Office 

of Government Ethics. 

[FR Doc. 2018–14840 Filed 7–10–18; 8:45 am] 

BILLING CODE 6345–03–P 

OFFICE OF GOVERNMENT ETHICS 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request for a Modified OGE 

Form 450 Executive Branch 

Confidential Financial Disclosure 

Report 

AGENCY: Office of Government Ethics 

(OGE). 

ACTION: Notice of request for agency and 

public comments. 

SUMMARY: After this first round notice 

and public comment period, the Office 

of Government Ethics (OGE) plans to 

submit a modified OGE Form 450 

Executive Branch Confidential Financial 

Disclosure Report to the Office of 

Management and Budget (OMB) for 

review and approval under the 

Paperwork Reduction Act of 1995. 

DATES: Written comments by the public 

and agencies on this proposed extension 

are invited and must be received by 

September 10, 2018. 

ADDRESSES: Comments may be 

submitted to OGE, by any of the 

following methods: 

Email: usoge@oge.gov (Include 

reference to ‘‘OGE Form 450 paperwork 

comment’’ in the subject line of the 

message.) 

FAX: 202–482–9237, Attn: Sara 

Nekou. 

Mail, Hand Delivery/Courier: Office of 

Government Ethics, 1201 New York 

Avenue NW, Suite 500, Attention: Sara 

Nekou, Assistant Counsel, Washington, 

DC 20005–3917. 

Instructions: Comments may be 

posted on OGE’s website, https://

www.oge.gov. Sensitive personal 

information, such as account numbers 

or Social Security numbers, should not 

be included. Comments generally will 

not be edited to remove any identifying 

or contact information. 

FOR FURTHER INFORMATION CONTACT: Sara 

Nekou at the U.S. Office of Government 

Ethics; telephone: 202–482–9229; TTY: 

800–877–8339; FAX: 202–482–9237; 

Email: snekou@oge.gov. An electronic 

copy of the OGE Form 450 is available 

in the Forms Library section of OGE’s 

website at https://www.oge.gov. A paper 

copy may also be obtained, without 

charge, by contacting Ms. Nekou. 

SUPPLEMENTARY INFORMATION: 

Title: Executive Branch Confidential 

Financial Disclosure Report. 

Agency Form Number: OGE Form 

450. 

OMB Control Number: 3209–0006. 

Type of Information Collection: 

Revision of a currently approved 

collection. 

Type of Review Request: Regular. 

Respondents: Prospective 

Government employees, including 

special Government employees, whose 

positions are designated for confidential 

disclosure filing and whose agencies 

require that they file new entrant 

confidential disclosure reports prior to 

assuming Government responsibilities. 

Estimated Annual Number of 

Respondents: 24,640. 

Estimated Time per Response: 3 

hours. 

Estimated Total Annual Burden: 

73,920 hours. 

Abstract: The OGE Form 450 collects 

information from covered department 

and agency employees as required 

under OGE’s executive branch wide 

regulatory provisions in subpart I of 5 

CFR part 2634. The basis for the OGE 

reporting regulation is section 201(d) of 

Executive Order 12674 of April 12, 1989 

(as modified by Executive Order 12731 

of October 17, 1990) and section 107(a) 

of the Ethics in Government Act, 5 

U.S.C. app. sec. 107(a). OGE proposes 

several modifications to the form. 

On October 5, 2016, OGE published a 

proposed rule for amending 5 CFR part 

2634. See 81 FR 69204–69238 (October 

5, 2016). The proposed modifications to 

the OGE Form 450 revise the 

instructions to reflect the changes to the 

financial disclosure regulation, if 

adopted as final. Specifically, OGE 

proposes to: Change the reporting 

periods for each part completed by new 

entrants; change the income disclosure 

threshold to $1,000 of received income; 

eliminate the disclosure of diversified 

funds held within an employee benefit 

plan; clarify that the disclosure 

requirement for agreements and 

arrangements includes those with a 

current employer; eliminate the 

disclosure of continued participation in 

a defined contribution plan to which an 

employer is no longer making 

contributions; and combine gifts and 

travel reimbursement into a single 


daltland on DSKBBV9HB2PROD with NOTICES
32124 Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices 

category for purposes of applying the 

disclosure thresholds. 

OGE is also proposing to update the 

Privacy Act Statement in accordance 

with changes to the applicable system of 

records, update the examples provided 

on the last page of the form, and make 

other minor technical changes. 

Request for Comments: OGE is 

publishing this first round notice of its 

intent to request paperwork clearance 

for a proposed modified OGE Form 450. 

Public comment is invited specifically 

on the need for and practical utility of 

this information collection, the accuracy 

of OGE’s burden estimate, the 

enhancement of quality, utility and 

clarity of the information collected, and 

the minimization of burden (including 

the use of information technology). 

Comments received in response to this 

notice will be summarized for, and may 

be included with, the OGE request for 

extension of OMB paperwork approval. 

The comments will also become a 

matter of public record. 

Approved: July 3, 2018. 

David Apol, 

Acting Director and General Counsel, Office 

of Government Ethics. 

[FR Doc. 2018–14841 Filed 7–10–18; 8:45 am] 

BILLING CODE 6345–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis Meeting (ACET) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Council for the 

Elimination of Tuberculosis Meeting 

(ACET). This meeting is open to the 

public, limited only by 60 room seating 

and 100 ports for audio phone lines. 

Time will be available for public 

comment. The public is welcome to 

submit written comments in advance of 

the meeting. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is Monday, August 

13, 2018. Persons who desire to make an 

oral statement, may request it at the 

time of the public comment period on 

August 21, 2018 at 3:20 p.m., EDT. 

DATES: The meeting will be held on 

August 21, 2018, 10:00 a.m. to 3:30 

p.m., EDT. 

ADDRESSES: 8 Corporate Blvd., Building 

8, Conference Rooms 1A and 1B, 

Atlanta, Georgia 30329 and Web 

conference: 1–877–927–1433 and 

participant passcode: 12016435 and 

https://adobeconnect.cdc.gov/ 

r5p8l2tytpq/. 

FOR FURTHER INFORMATION CONTACT: 

Margie Scott-Cseh, Committee 

Management Specialist, CDC, 1600 

Clifton Road NE, Mailstop: E–07, 

Atlanta, Georgia 30329–4018, telephone 

(404) 639–8317; zkr7@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: This Council advises and 

makes recommendations to the 

Secretary of Health and Human 

Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding 

the elimination of tuberculosis. 

Specifically, the Council makes 

recommendations regarding policies, 

strategies, objectives, and priorities; 

addresses the development and 

application of new technologies; and 

reviews the extent to which progress has 

been made toward eliminating 

tuberculosis. 

Matters To Be Considered: The agenda 

will include discussions on (1) 

Isoniazid-Rifapentine TB Prevention in 

HIV-infected Persons Study; (2) Division 

of HIV/AIDS Prevention’s Strategy of 

Adopting HIV Treatment as Prevention; 

(3) Update on Division of Tuberculosis 

Elimination’s Concept of Operations for 

Latent Tuberculosis Infection 

Surveillance; and (4) Update from ACET 

workgroups. Agenda items are subject to 

change as priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–14755 Filed 7–10–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women, Centers for Disease 

Control and Prevention; Notice of 

Charter Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of charter renewal. 

SUMMARY: This gives notice under the 

Federal Advisory Committee Act of 

October 6, 1972, that the Advisory 

Committee on Breast Cancer in Young 

Women (ACBCYW), Centers for Disease 

Control and Prevention, Department of 

Health and Human Services, has been 

renewed for a 2-year period through 

June 17, 2020. 

FOR FURTHER INFORMATION CONTACT: 

Temeika L. Fairley, Ph.D., Designated 

Federal Officer, National Center for 

Chronic Disease Prevention and Health 

Promotion, CDC, 5770 Buford Highway 

NE, Mailstop K52, Atlanta, Georgia 

30341, Telephone (770) 488–4518, Fax 

(770) 488–4760. Email: acbcyw@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–14756 Filed 7–10–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–0572] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Health Message 

Testing System (HMTS) to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 


daltland on DSKBBV9HB2PROD with NOTICES